PTEN is among the most commonly inactivated or mutated tumor suppressor genes in human cancers [58], with approximately 70% of advanced PCa cases exhibiting PTEN loss or consequent hyperactivation of the PI3K/Akt/mTOR pathway [59]. The gene discussed is AKT1; the disease is posterior cortical atrophy.